Opportunity Information: Apply for CDC RFA GH11 11111
Apply for CDC RFA GH11 11111
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Cooperative Agreement with the Bangkok Metropolitan Administration (BMA) in the Kingdom of Thailand" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Mar 29, 2011 and posted on Mar 21, 2011.
- Applicants must submit their applications by Jun 17, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $500,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Assistance will be provided only to the Bangkok Metropolitan Administration (BMA), Kingdom of Thailand. No other applications are solicited.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Cooperative Agreement with the Bangkok Metropolitan Administration (BMA) in the Kingdom of Thailand is a Centers for Disease Control and Prevention (CDC) discretionary funding opportunity designed to strengthen Thailand's public health capacity through a close, collaborative CDC-BMA partnership. Structured as a cooperative agreement, it emphasizes active involvement and technical engagement rather than a hands-off grant. The overall intent is to improve population health outcomes by expanding surveillance and epidemiology, upgrading laboratory and diagnostic systems, and putting evidence-based public health programs into practice across a wide range of priority health threats that affect illness, premature death, and quality of life.
A major focus of the agreement is building and improving national-level public health surveillance and epidemiological assessment. This includes collecting and analyzing data to understand disease patterns, detect outbreaks earlier, and guide response strategies. The opportunity highlights infectious disease priorities such as HIV/AIDS, including specific safety and quality components like blood safety, injection safety, infection control, and medical waste management. It also covers malaria; emerging and re-emerging infections; neglected tropical diseases; tuberculosis; influenza; zoonotic diseases; vector-borne diseases; and other pathogens with pandemic potential. In addition to infectious diseases, the agreement explicitly extends to environmental health issues, chronic diseases, maternal and child health, reproductive health, public health preparedness, biosafety, and injury control and prevention. The scope signals an integrated approach: improving core public health functions (surveillance, labs, preparedness, program delivery) so they can be applied across many health domains.
Another central pillar is workforce development and training. The agreement aims to provide practical training opportunities for a broad set of public health professionals and implementers, including laboratory staff, BMA staff, and selected university and graduate-level students, along with others involved in program delivery. Training topics include health assessment and epidemiology, evidence-based program planning, program implementation, program evaluation, and data collection and analysis. It also includes management competencies such as personnel, financial, and administrative management, reflecting an understanding that strong public health programs require not only technical expertise but also solid operational and governance capacity to sustain results.
The opportunity also aims to strengthen BMA's institutional ability to plan, implement, and evaluate evidence-based public health programs. This includes enhancing BMA's capacity to run surveillance systems, perform epidemiological analysis, and use those insights to support disease prevention and control efforts at both national and regional levels. In practical terms, this is about making BMA better equipped to detect health threats, interpret what the data mean, prioritize interventions, and coordinate responses that align with broader public health goals beyond Bangkok, contributing to Thailand's overall health security and regional preparedness.
A final emphasis is on learning and continuous improvement through program evaluation. The agreement calls for evaluation results to be incorporated back into operational disease prevention and control programs, so lessons translate into real changes in how programs are run. It also stresses sharing expertise and lessons learned nationally, regionally, and internationally, supporting broader dissemination of effective practices. The stated end goal is to use evidence generated from program implementation and evaluation to inform science-based health policies and guidelines, helping ensure that public health decisions are grounded in data and proven approaches rather than assumptions.
Administratively, this opportunity is identified as Funding Opportunity Number CDC RFA GH11 11111 under CFDA 93.283 (CDC Investigations and Technical Assistance). CDC anticipated a single award, with an estimated total funding amount of USD 500,000. There is no cost sharing or matching requirement. The opportunity was posted on March 21, 2011, created on March 29, 2011, and closed on June 17, 2011, with an archive date of July 17, 2011. Eligibility is highly restricted: assistance is provided only to the Bangkok Metropolitan Administration, and no other applications are solicited, meaning it is a targeted award intended specifically for BMA rather than an open competition. For access issues related to the full announcement, the listed point of contact was the CDC Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is a CDC discretionary funding opportunity structured as a cooperative agreement with the Bangkok Metropolitan Administration (BMA) in the Kingdom of Thailand. Its purpose is to strengthen Thailand's public health capacity through a close, collaborative CDC-BMA partnership.
What does it mean that this is a "cooperative agreement"?
In this opportunity, a cooperative agreement is designed for active CDC involvement and technical engagement, rather than a more hands-off grant. The emphasis is on collaboration between CDC and BMA while implementing the work.
What is the overall goal of the cooperative agreement?
The overall intent is to improve population health outcomes by expanding surveillance and epidemiology, upgrading laboratory and diagnostic systems, and implementing evidence-based public health programs across priority health threats that contribute to illness, premature death, and reduced quality of life.
Which organization is the award intended for?
Eligibility is highly restricted. Assistance is provided only to the Bangkok Metropolitan Administration (BMA), and no other applications are solicited.
Is this an open competitive funding opportunity?
No. The announcement indicates it is a targeted award intended specifically for BMA, and no other applications are solicited.
How many awards did CDC anticipate making under this opportunity?
CDC anticipated a single award.
What is the estimated total funding amount?
The estimated total funding amount listed for this opportunity is USD 500,000.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
What is the Funding Opportunity Number and CFDA number?
The Funding Opportunity Number is CDC RFA GH11 11111. The CFDA listing is 93.283 (CDC Investigations and Technical Assistance).
What are the main technical focus areas of the agreement?
The agreement focuses on strengthening core public health functions, including: (1) surveillance and epidemiology, (2) laboratory and diagnostic systems, (3) evidence-based program implementation, and (4) preparedness and related public health capacity that can be applied across many health domains.
What does the opportunity say about surveillance and epidemiology?
A major focus is building and improving national-level public health surveillance and epidemiological assessment. This includes collecting and analyzing data to understand disease patterns, detect outbreaks earlier, and guide response strategies.
Which infectious disease priorities are mentioned?
The opportunity highlights infectious disease priorities including HIV/AIDS, malaria, emerging and re-emerging infections, neglected tropical diseases, tuberculosis, influenza, zoonotic diseases, vector-borne diseases, and other pathogens with pandemic potential.
Are HIV/AIDS-related safety and quality issues included in scope?
Yes. The HIV/AIDS scope specifically includes safety and quality components such as blood safety, injection safety, infection control, and medical waste management.
Does the scope include non-infectious health issues as well?
Yes. In addition to infectious diseases, the agreement explicitly extends to environmental health issues, chronic diseases, maternal and child health, reproductive health, public health preparedness, biosafety, and injury control and prevention.
What does "integrated approach" mean in the context of this agreement?
The scope signals an integrated approach by strengthening core public health functions (like surveillance, laboratory capacity, preparedness, and program delivery) so they can be applied across many different health threats and health domains.
What laboratory-related improvements are part of the intent?
The opportunity includes upgrading laboratory and diagnostic systems as part of strengthening public health capacity.
Is workforce development included?
Yes. Workforce development and training is a central pillar of the agreement.
Who are the intended trainees or participants in training activities?
The agreement aims to provide practical training opportunities for a broad set of public health professionals and implementers, including laboratory staff, BMA staff, selected university and graduate-level students, and others involved in program delivery.
What training topics are specifically mentioned?
Training topics include health assessment and epidemiology, evidence-based program planning, program implementation, program evaluation, and data collection and analysis.
Are management and administrative skills included in the training scope?
Yes. The opportunity also includes management competencies such as personnel, financial, and administrative management, recognizing that strong programs require operational and governance capacity to sustain results.
How does the agreement aim to strengthen BMA institutionally?
It aims to strengthen BMA's institutional ability to plan, implement, and evaluate evidence-based public health programs, including enhancing capacity to run surveillance systems, perform epidemiological analysis, and use insights to support disease prevention and control.
Is the work intended to support only Bangkok, or broader public health goals too?
The description indicates benefits beyond Bangkok. It emphasizes supporting disease prevention and control efforts at national and regional levels and contributing to Thailand's overall health security and regional preparedness.
What role does program evaluation play in this agreement?
Learning and continuous improvement through program evaluation is emphasized. The agreement calls for evaluation results to be incorporated back into operational disease prevention and control programs so lessons learned translate into real program changes.
Does the opportunity mention sharing results or lessons learned?
Yes. It stresses sharing expertise and lessons learned nationally, regionally, and internationally to support broader dissemination of effective practices.
How are evidence and evaluation expected to influence policy?
The stated end goal includes using evidence generated from program implementation and evaluation to inform science-based health policies and guidelines, supporting public health decision-making grounded in data and proven approaches.
When was the opportunity posted, and what were the key dates?
The opportunity was posted on March 21, 2011; created on March 29, 2011; closed on June 17, 2011; and had an archive date of July 17, 2011.
Is this opportunity still open?
No. Based on the provided dates, the opportunity closed on June 17, 2011 and was archived on July 17, 2011.
Who should be contacted for access issues related to the full announcement?
For access issues, the listed point of contact is the CDC Procurement and Grants Office Technical Information Management Section (TIMS) at 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: National Park Service Continuing Documentation of Archaeological Sites Impacted by Illegal Border Activities within the NPS Unit of Coronado National Memorial (CORO)
Previous opportunity: Instructions for Preparing an Interim Progress Report State Vital Statistics Improvement Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 11111
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 11111) also looked into and applied for these:
| Funding Opportunity |
|---|
| Assessments And Surveys For Public Health Action In Post Earthquake Haiti Apply for RFA GH 11 007 Funding Number: RFA GH 11 007 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Training Center Apply for HRSA 11 142 Funding Number: HRSA 11 142 Agency: Health Resources and Services Administration Category: Health Funding Amount: $650,000 |
| Human Immunodeficiency Virus (HIV) Prevention Projects for Young Men of Color Who Have Sex with Men and Young Transgender Persons of Color Apply for CDC RFA PS11 1113 Funding Number: CDC RFA PS11 1113 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Public Prevention Health Fund Strengthening Public Health Infrastructure for Improved Health Outcomes AKA National Public Health Improvement Initiative Apply for CDC RFA CD10 101101PPHF11 Funding Number: CDC RFA CD10 101101PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,093,164 |
| Surveillance of Birth Defects in Low and Middle Income Countries Apply for CDC RFA DD11 1104 Funding Number: CDC RFA DD11 1104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Engaging State/Local Emergency Management Agencies to Improve Apply for CDC RFA TP10 100402CONT11 Funding Number: CDC RFA TP10 100402CONT11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NINDS Program Project Grant (P01) Apply for PAR 11 172 Funding Number: PAR 11 172 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Recovery Community Services Program (RCSP) Supplements Apply for TI 11 004 Funding Number: TI 11 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $150,000 |
| DNA Repository for the NIAAA National Epidemiologic Survey on Alcohol and Related ConditionsIII (NESARCIII) (U24) Apply for RFA AA 12 001 Funding Number: RFA AA 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $2,700,000 |
| NINDS PHASE III Investigator Initiated Multi Site Clinical Trials (U01) Apply for PAR 11 173 Funding Number: PAR 11 173 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| A Grand Challenge for Development Apply for RFA OAA 11 000006 Funding Number: RFA OAA 11 000006 Agency: USAID Category: Health Funding Amount: $2,000,000 |
| Program Project on Alcohol Related Research (P01) Apply for PAR 11 174 Funding Number: PAR 11 174 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Institute on Aging Request for Applications for an Alzheimers Disease Genetics Data Warehouse (U24) Apply for PAR 11 175 Funding Number: PAR 11 175 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cooperative Agreement with the Ministry of Public Health in the Kingdom of Thailand (MOPH) Apply for CDC RFA GH11 11110 Funding Number: CDC RFA GH11 11110 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Competitive Program Expansion Supplement for CDC RFA HM08 805 Strengthen and Improve the Nation s Capacity through National, Non profit, Professional Public Health Organizations to Increase Health Protection and Health Equity Apply for CDC RFA HM08 8050402PHFF11 Funding Number: CDC RFA HM08 8050402PHFF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Addressing Global TB And Domestic TB Of All Forms Including TB/HIV In All Populations And In All Settings To Prevent, Control TB And Other Programmatic Activities Involved In Eliminating TB Apply for CDC RFA PS11 1111 Funding Number: CDC RFA PS11 1111 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,000,000 |
| Effective Strategies to Reduce Motor Vehicle Injuries Among American Indians/Alaska Natives (Teens) Apply for CDC RFA CE10 10010201SUPP11 Funding Number: CDC RFA CE10 10010201SUPP11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $32,000 |
| Saath Saath Project (SSP) for USAID/Nepal Apply for RFA 367 11 000002 Funding Number: RFA 367 11 000002 Agency: Nepal USAID Kathmandu Category: Health Funding Amount: $27,500,000 |
| FANIKISHA Institutional Strengthening Project Apply for RFA 623 11 000004 Funding Number: RFA 623 11 000004 Agency: Kenya USAID Nairobi Category: Health Funding Amount: $44,000,000 |
| High Throughput Enabled Structural Biology Partnerships (U01) Apply for PAR 11 176 Funding Number: PAR 11 176 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 11111", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.